Lynparza Combo Approved for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
Lynparza is a poly polymerase inhibitor.
Lynparza is a poly polymerase inhibitor.
Paxlovid has been taken by seniors and others at high risk for severe COVID-19 under an emergency use approval
Padcev is a Nectin-4-directed antibody and microtubule inhibitor conjugate; Keytruda is a programmed death receptor-1-blocking antibody.
A pressure sensor at the tip of the ureteroscope provides real-time measurements.
Red flags include pharmacies that do not require a doctor’s prescription or have a licensed pharmacist to answer questions
For patients who tolerated and remained on therapy, the average treatment effect on serum phosphorus was about -0.7mg/dL.
The agency has issued proposed draft recommendations to guide incorporation of cybersecurity protections into medical devices at the time of manufacture.
The source of the chemicals is from the silicone tubing used as a part of the hydraulics in the machine and the dialysate lines.
Extrapolation of the findings from pivotal clinical trials to the approved indication most common for disease severity
The NDA submission included data from 36 clinical trials involving over 8000 patients.